多発性骨髄腫トップ企業
-
Bristol-Myers Squibb Company
-
Takeda Pharmaceutical Company Limited
-
Amgen Inc.
-
Sanofi S.A.
-
Karyopharm Therapeutics Inc.
*免責事項:上位企業は順不同
Bristol-Myers Squibb Company
Takeda Pharmaceutical Company Limited
Amgen Inc.
Sanofi S.A.
Karyopharm Therapeutics Inc.
*免責事項:上位企業は順不同